Thyme Companies Names Flatiron Health Ex-CEO Starrett to Lead New Ventures
Nashville, Tenn. – – September 29, 2026 -- Thyme Companies has appointed Carolyn Starrett as executive vice president of new ventures, tasking her with identifying and scaling new businesses beyond its existing Thyme Care platform. Starrett reports directly to Executive Chairman Robin Shah, marking her second collaboration with him after their tenure together at Flatiron Health.
Starrett brings a decade of oncology data leadership from Flatiron Health
Starrett joined Flatiron Health in 2016 alongside Thyme's founders and served as its Chief Executive Officer from 2021 to 2025. Under her leadership, Flatiron's real-world evidence platform expanded from roughly 400,000 to more than 5.5 million patient records. Its OncoEMR platform grew to serve more than 4,500 oncology providers nationwide, while the company extended research operations into the United Kingdom, Germany and Japan.